2014, Number 5
Efecto de la dieta KOT sobre el riesgo aterogénico en mujeres obesas
Language: Spanish
References: 12
Page: 6-15
PDF size: 458.16 Kb.
ABSTRACT
The profile of lipids is an indicator of aterogenic risk. Diets exist hiperproteic, low-calorie with low index glucemic and rich in fiber as the diet KOT that probably diminishes the aterogenic risk. The KOT diet (designed by CEPRODI-KOT in France), they consist of a set of food formulae created by specialists of nutrition. The aim of this work is to demonstrate that the consumption of a diet KOT for two weeks, can support inside normal limits the levels of cholesterol, tryglicerides, HDLc, LDLc and diminish the aterogenic risk in adult obese women. This investigation is quasi-experimental, market, longitudinal, and analytical. The results showed decreases in all the indicators of the profile of lipids and in the aterogenic risk, nevertheless, only the cholesterol showed that this decrease was statistically significant. The diet KOT protects against the aterogenic risk but it is suggested that his consumption should be superior to two weeks. Key words: Aterogenic risk, Obesity,REFERENCES
Cámara de diputados H. Congreso de la Unión. LXII Legislatura (Últimas actualizaciones) [Internet]. Reglamento de la Ley General de Salud en Materia de Investigación para la Salud. [Internet]. Diario Oficial de la Federación; 1986. Recuperado a partir de : http://www. diputados.gob.mx/LeyesBiblio/actual/2014_1.htm.:
Salwa W Rizcalla, Edi Prifti, Aurelie Cotillard, Veronique Pelloux, Cristine Rouault, Reginald Allouiche, et al. Differential effects of macronutrient content in 2 energyrestricted diets on cardiovascular risk factors and adipose tissue cell size in moderately obese individuals: a randomized controlled trial. Am J Clin Nutr 2012;95:49-63.
Rodríguez Perón JM, Mora González SR, Acosta Cabrera EB, Pérez Salido JA, Fernández de la Rosa R, Hernández Sandoval M, et al. Utilización de un índice pronóstico de morbilidad y mortalidad por enfermedad cardiovascular asociada con factores de riesgo aterogénico. Rev Cuba Med Mil. junio de 2002;31(2):87-93.